Biocorrx (OTCMKTS:BICX) Announces Earnings Results, Beats Expectations By $0.03 EPS

Biocorrx (OTCMKTS:BICX) announced its quarterly earnings results on Friday. The company reported ($0.03) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.03, Zacks reports.

Biocorrx Stock Up 20.9%

BICX traded up $0.09 on Friday, reaching $0.49. The company had a trading volume of 27,821 shares, compared to its average volume of 7,777. Biocorrx has a 1 year low of $0.20 and a 1 year high of $1.28. The stock has a market capitalization of $14.36 million, a PE ratio of -2.60 and a beta of 0.17. The stock has a 50-day moving average price of $0.37 and a 200-day moving average price of $0.35.

About Biocorrx

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.